Intellectual Property India Publishes Patent Application for 'Amide Derivatives For Inhibiting Nlrp3 And Uses Thereof' Filed by Ventus Therapeutics U. S. Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099291 A) filed by Ventus Therapeutics U. S. Inc., Waltham, U.S.A., on Oct. 14, for 'amide derivatives for inhibiting nlrp3 and uses thereof.'

Inventor(s) include Dorich, Stephane; Beveridge, Ramsay E.; Ciblat, Stephane; Cote, Alexandre; Cyr, Patrick; and St-Onge, Miguel.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to compounds of Formula (I-A): and pharmaceutically acceptable salts and tautomers thereof, wherein Ring A, Ring B, R1, R2a, R2b, R3, m, n, and p are described herein, and methods of preparation, methods of treatment and prevention, and pharmaceutical compositions comprising same. The present disclosure further relates to the use of the compounds of Formula (I-A), and pharmaceutically acceptable salts and tautomers thereof, in the treatment and prevention of NLRP3-related diseases and disorders."

The patent application was internationally filed on Mar. 15, 2024, under International application No.PCT/US2024/020220.

Disclaimer: Curated by HT Syndication.